Manufacturer of Controlled Substances; Notice of Application, 43814 [E6-12457]
Download as PDF
<![CDATA[
43814
Federal Register / Vol. 71, No. 148 / Wednesday, August 2, 2006 / Notices
controlled substances listed in
Schedules II:
Drug
Schedule
Methylphenidate (1724) ................
Phenylacetone (8501) ..................
Methadone intermediate (9254) ...
II
II
II
The company plans to manufacture
the listed controlled substance in bulk
for sale to its customer.
Any other such applicant and any
person who is presently registered with
DEA to manufacture such a substance
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections being sent via regular mail
should be addressed, in quintuplicate,
to the Deputy Assistant Administrator,
Office of Diversion Control, Drug
Enforcement Administration,
Washington, DC. 20537, Attention: DEA
Federal Register Representative/ODL; or
any being sent via express mail should
be sent to DEA Headquarters, Attention:
DEA Federal Register Representative/
ODL, 2401 Jefferson-Davis Highway,
Alexandria, Virginia 22301; and must be
filed no later than October 2, 2006.
Dated: July 26, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E6–12455 Filed 8–1–06; 8:45 am]
BILLING CODE 4410–09–P
should be addressed, in quintuplicate,
to the Deputy Assistant Administrator,
Office of Diversion Control, Drug
Enforcement Administration,
Washington, DC. 20537, Attention: DEA
Federal Register Representative/ODL; or
any being sent via express mail should
be sent to DEA Headquarters, Attention:
DEA Federal Representative/ODL, 2401
Jefferson-Davis Highway, Alexandria,
Virginia 22301; and must be filed no
later than October 2, 2006.
Dated: July 26, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E6–12457 Filed 8–1–06; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
BILLING CODE 4410–09–P
Pursuant to Section 1301.33(a) of Title
21 of the Code of Federal Regulations
(CFR), this is notice that on February 19,
2006, Orasure Technologies, Inc.,
Lehigh University, Seeley G. MuddBuilding 6, Bethlehem, Pennsylvania
18015, made application by renewal,
and by letter, to the Drug Enforcement
Administration (DEA) to be registered as
a bulk manufacturer of the basic classes
of controlled substances listed in
Schedule I and II:
DEPARTMENT OF JUSTICE
Drug
wwhite on PROD1PC61 with NOTICES
Manufacturer of Controlled
Substances; Notice of Application
Pursuant to Section 1301.33(a) Title
21 of the Code of Federal Regulations
(CFR), this is notice that on June 27,
2006, Noramco Inc., 1440 Olympic
Drive, Athens, Georgia 30601, made
application by letter to the Drug
Enforcement Administration (DEA) for
registration as a bulk manufacturer of
basic drug code (1724)
methylphenidate.
The company plans to bulk
manufacture methylphenidate for a
customer to use in the production of a
controlled substance product.
Any other such applicant and any
person who is presently registered with
DEA to manufacture such a substance
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections being sent via regular mail
VerDate Aug<31>2005
16:40 Aug 01, 2006
Jkt 208001
Dated: July 26, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E6–12459 Filed 8–1–06; 8:45 am]
Manufacturer of Controlled
Substances; Notice of Application
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR § 1301.33(a).
Any such written comments or
objections being sent via regular mail
may be addressed, in quintuplicate, to
the Deputy Assistant Administrator,
Office of Diversion Control, Drug
Enforcement Administration,
Washington, DC. 20537, Attention: DEA
Federal Register Representative, Liaison
and Policy Section (ODL); or any being
sent via express mail should be sent to
DEA Headquarters, Attention: DEA
Federal Register Representative/ODL,
2401 Jefferson-Davis Highway,
Alexandria, Virginia 22301; and must be
filed no later than October 2, 2006.
Schedule
Lysergic acid diethylamide (LSD)
(7315).
4–Methoxyamphetamine (7411) ...
Normorphine (9313) .....................
Tetrahydrocannabinols
(THC)
(7370).
Alphamethadol (9605) ..................
Amphetamine (1100) ....................
Methamphetamine (1105) ............
Cocaine (9041) .............................
Hydromorphone (9150) ................
Benzoylecgonine (9180) ...............
Hydrocodone (9193) .....................
Morphine (9300) ...........................
Oxycodone (9143) ........................
Meperidine (9230) ........................
Methadone (9250) ........................
Oxymorphone (9652) ...................
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
The company plans to manufacture
the listed controlled substances in bulk
to manufacture controlled substance
derivatives. These derivatives will be
used in diagnostic products created
specifically for internal use only.
Any other such applicant and any
person who is presently registered with
DEA to manufacture such a substance
PO 00000
Frm 00105
Fmt 4703
Sfmt 4703
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Application
Pursuant to Section 1301.33(a) of Title
21 of the Code of Federal Regulations
(CFR), this is notice that on January 10,
2006, Siegfried (USA), Inc., Industrial
Park Road, Pennsville, New Jersey
08070, made application by renewal to
the Drug Enforcement Administration
(DEA) to be registered as a bulk
manufacturer of the basic classes of
controlled substances listed in Schedule
II:
Drug
Amphetamine (1100) ....................
Methylphenidate (1724) ................
Amobarbital (2125) .......................
Pentobarbital (2270) .....................
Secobarbital (2315) ......................
Glutethimide (2550) ......................
Codeine (9050) .............................
Oxycodone (9143) ........................
Hydromorphone (9150) ................
Hydrocodone (9193) .....................
Methadone (9250) ........................
Methadone intermediate (9254) ...
Dextropropoxyphene, bulk (nondosage forms) (9273).
Morphine (9300) ...........................
Schedule
II
II
II
II
II
II
II
II
II
II
II
II
II
II
The company plans to manufacture
the listed controlled substances in bulk
for distribution to its customers.
Any other such applicant and any
person who is presently registered with
DEA to manufacture such a substance
may file comments or objections to the
E:\FR\FM\02AUN1.SGM
02AUN1
]]>Agencies
[Federal Register Volume 71, Number 148 (Wednesday, August 2, 2006)]
[Notices]
[Page 43814]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-12457]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application
Pursuant to Section 1301.33(a) Title 21 of the Code of Federal
Regulations (CFR), this is notice that on June 27, 2006, Noramco Inc.,
1440 Olympic Drive, Athens, Georgia 30601, made application by letter
to the Drug Enforcement Administration (DEA) for registration as a bulk
manufacturer of basic drug code (1724) methylphenidate.
The company plans to bulk manufacture methylphenidate for a
customer to use in the production of a controlled substance product.
Any other such applicant and any person who is presently registered
with DEA to manufacture such a substance may file comments or
objections to the issuance of the proposed registration pursuant to 21
CFR 1301.33(a).
Any such written comments or objections being sent via regular mail
should be addressed, in quintuplicate, to the Deputy Assistant
Administrator, Office of Diversion Control, Drug Enforcement
Administration, Washington, DC. 20537, Attention: DEA Federal Register
Representative/ODL; or any being sent via express mail should be sent
to DEA Headquarters, Attention: DEA Federal Representative/ODL, 2401
Jefferson-Davis Highway, Alexandria, Virginia 22301; and must be filed
no later than October 2, 2006.
Dated: July 26, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E6-12457 Filed 8-1-06; 8:45 am]
BILLING CODE 4410-09-P
